Adriana Ortega

886 total citations
13 papers, 379 citations indexed

About

Adriana Ortega is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Adriana Ortega has authored 13 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Medicine, 9 papers in Pharmacology and 5 papers in Epidemiology. Recurrent topics in Adriana Ortega's work include Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Bacterial Identification and Susceptibility Testing (4 papers). Adriana Ortega is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Bacterial Identification and Susceptibility Testing (4 papers). Adriana Ortega collaborates with scholars based in Spain, Netherlands and Germany. Adriana Ortega's co-authors include Jesús Oteo, José Campos, Belén Aracil, Marı́a Pérez-Vázquez, Sara Fernández-Romero, Noelia Lara, David Saéz, Verónica Bautista, Germán Bou and Luis Martínez‐Martínez and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Adriana Ortega

13 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adriana Ortega Spain 11 317 151 100 83 77 13 379
Silke Polsfuß Switzerland 8 322 1.0× 137 0.9× 97 1.0× 80 1.0× 93 1.2× 9 443
Celeste Lucero Argentina 13 327 1.0× 153 1.0× 87 0.9× 72 0.9× 80 1.0× 25 424
Silvia Bracco Italy 9 337 1.1× 156 1.0× 90 0.9× 78 0.9× 84 1.1× 12 390
Alejandro Sánchez-Pérez Mexico 14 345 1.1× 162 1.1× 77 0.8× 62 0.7× 58 0.8× 22 400
Kathy‐Anne Strydom South Africa 8 378 1.2× 175 1.2× 73 0.7× 126 1.5× 80 1.0× 13 454
V. Bautista Spain 6 335 1.1× 170 1.1× 149 1.5× 60 0.7× 68 0.9× 7 434
Camila Rizek Brazil 13 332 1.0× 167 1.1× 106 1.1× 104 1.3× 55 0.7× 28 442
Carly Kubasek United States 6 251 0.8× 121 0.8× 73 0.7× 61 0.7× 118 1.5× 9 357
Daniela Cejas Argentina 12 347 1.1× 183 1.2× 75 0.8× 80 1.0× 132 1.7× 28 458
Mar Solé Spain 10 320 1.0× 154 1.0× 73 0.7× 75 0.9× 46 0.6× 10 445

Countries citing papers authored by Adriana Ortega

Since Specialization
Citations

This map shows the geographic impact of Adriana Ortega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adriana Ortega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adriana Ortega more than expected).

Fields of papers citing papers by Adriana Ortega

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adriana Ortega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adriana Ortega. The network helps show where Adriana Ortega may publish in the future.

Co-authorship network of co-authors of Adriana Ortega

This figure shows the co-authorship network connecting the top 25 collaborators of Adriana Ortega. A scholar is included among the top collaborators of Adriana Ortega based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adriana Ortega. Adriana Ortega is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Esteban-Cantos, Andrés, Belén Aracil, Verónica Bautista, et al.. (2017). The Carbapenemase-Producing Klebsiella pneumoniae Population Is Distinct and More Clonal than the Carbapenem-Susceptible Population. Antimicrobial Agents and Chemotherapy. 61(4). 21 indexed citations
2.
Arana, David M., Adriana Ortega, Eva M. González‐Barberá, et al.. (2017). Carbapenem-resistant Citrobacter spp. isolated in Spain from 2013 to 2015 produced a variety of carbapenemases including VIM-1, OXA-48, KPC-2, NDM-1 and VIM-2. Journal of Antimicrobial Chemotherapy. 72(12). 3283–3287. 42 indexed citations
3.
Pérez-Vázquez, Marı́a, Jesús Oteo, Silvia García-Cobos, et al.. (2016). Phylogeny, resistome and mobile genetic elements of emergent OXA-48 and OXA-245Klebsiella pneumoniaeclones circulating in Spain. Journal of Antimicrobial Chemotherapy. 71(4). 887–896. 28 indexed citations
4.
Oteo, Jesús, Marı́a Pérez-Vázquez, Verónica Bautista, et al.. (2016). The spread of KPC-producing Enterobacteriaceae in Spain: WGS analysis of the emerging high-risk clones ofKlebsiella pneumoniaeST11/KPC-2, ST101/KPC-2 and ST512/KPC-3. Journal of Antimicrobial Chemotherapy. 71(12). 3392–3399. 62 indexed citations
5.
Ortega, Adriana, David Saéz, Verónica Bautista, et al.. (2016). Carbapenemase-producingEscherichia coliis becoming more prevalent in Spain mainly because of the polyclonal dissemination of OXA-48. Journal of Antimicrobial Chemotherapy. 71(8). 2131–2138. 47 indexed citations
6.
Fernández-Martínez, Marta, Elisenda Miró, Adriana Ortega, et al.. (2015). Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain. International Journal of Antimicrobial Agents. 46(2). 157–163. 31 indexed citations
7.
Diez‐Aguilar, María, et al.. (2015). Establishing the validity of different susceptibility testing methods to evaluate the in vitro activity of amoxicillin-clavulanate against Escherichia coli. Diagnostic Microbiology and Infectious Disease. 84(4). 334–336. 2 indexed citations
8.
Diez‐Aguilar, María, María‐Isabel Morosini, Lorena López‐Cerero, et al.. (2015). Performance of EUCAST and CLSI approaches for co-amoxiclav susceptibility testing conditions for clinical categorization of a collection of Escherichia coli isolates with characterized resistance phenotypes. Journal of Antimicrobial Chemotherapy. 70(8). 2306–2310. 10 indexed citations
9.
Oviaño, Marina, B. Fernández, Adriana Ortega, et al.. (2015). Rapid Detection of OXA-48-Producing Enterobacteriaceae by Matrix-Assisted Laser Desorption Ionization−Time of Flight Mass Spectrometry. Journal of Clinical Microbiology. 54(3). 754–759. 22 indexed citations
10.
Oteo, Jesús, Juan José González‐López, Adriana Ortega, et al.. (2014). Inhibitor-Resistant TEM- and OXA-1-Producing Escherichia coli Isolates Resistant to Amoxicillin-Clavulanate Are More Clonal and Possess Lower Virulence Gene Content than Susceptible Clinical Isolates. Antimicrobial Agents and Chemotherapy. 58(7). 3874–3881. 18 indexed citations
11.
Rodríguez‐Baño, Jesús, Jesús Oteo, Adriana Ortega, et al.. (2013). Epidemiological and Clinical Complexity of Amoxicillin-Clavulanate-Resistant Escherichia coli. Journal of Clinical Microbiology. 51(7). 2414–2417. 12 indexed citations
12.
Ortega, Adriana, Jesús Oteo, Maitane Aranzamendi, et al.. (2012). Spanish Multicenter Study of the Epidemiology and Mechanisms of Amoxicillin-Clavulanate Resistance in Escherichia coli. Antimicrobial Agents and Chemotherapy. 56(7). 3576–3581. 47 indexed citations
13.
Samper, Sofía, María José Iglesias, María José Rabanaque, et al.. (2005). Systematic Molecular Characterization of Multidrug-Resistant Mycobacterium tuberculosis Complex Isolates from Spain. Journal of Clinical Microbiology. 43(3). 1220–1227. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silke Polsfuß Breakdown of academic impact, for papers by Celeste Lucero Breakdown of academic impact, for papers by Silvia Bracco Breakdown of academic impact, for papers by Alejandro Sánchez-Pérez Breakdown of academic impact, for papers by Kathy‐Anne Strydom Breakdown of academic impact, for papers by V. Bautista Breakdown of academic impact, for papers by Camila Rizek Breakdown of academic impact, for papers by Carly Kubasek Breakdown of academic impact, for papers by Daniela Cejas Breakdown of academic impact, for papers by Mar Solé
Rankless by CCL
2026